Atomoxetine
- Product NDC
- 60687-567
- 11-digit product format
- 606870567
- Labeler code
- 60687
- Product ID
- 60687-567_2759be5a-a8a1-2119-e063-6394a90a38ac
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Atomoxetine
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- American Health Packaging
- Application
- ANDA079016
- Marketing category
- ANDA
- Marketing start
- 2020-12-07
- Substance
- ATOMOXETINE HYDROCHLORIDE
- Active strength
- 25 mg/1
- Pharmacologic classes
- Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A079016-001 | ATOMOXETINE HYDROCHLORIDE | ATOMOXETINE HYDROCHLORIDE | EQ 10MG BASE | CAPSULE / ORAL | AB | 2017-05-30 | |
| A079016-002 | ATOMOXETINE HYDROCHLORIDE | ATOMOXETINE HYDROCHLORIDE | EQ 18MG BASE | CAPSULE / ORAL | AB | 2017-05-30 | |
| A079016-003 | ATOMOXETINE HYDROCHLORIDE | ATOMOXETINE HYDROCHLORIDE | EQ 25MG BASE | CAPSULE / ORAL | AB | 2017-05-30 | |
| A079016-004 | ATOMOXETINE HYDROCHLORIDE | ATOMOXETINE HYDROCHLORIDE | EQ 40MG BASE | CAPSULE / ORAL | AB | 2017-05-30 | |
| A079016-005 | ATOMOXETINE HYDROCHLORIDE | ATOMOXETINE HYDROCHLORIDE | EQ 60MG BASE | CAPSULE / ORAL | AB | 2017-05-30 | |
| A079016-006 | ATOMOXETINE HYDROCHLORIDE | ATOMOXETINE HYDROCHLORIDE | EQ 80MG BASE | CAPSULE / ORAL | AB | 2017-05-30 | |
| A079016-007 | ATOMOXETINE HYDROCHLORIDE | ATOMOXETINE HYDROCHLORIDE | EQ 100MG BASE | CAPSULE / ORAL | AB | 2017-05-30 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A079016-001 | AB |
| A079016-002 | AB |
| A079016-003 | AB |
| A079016-004 | AB |
| A079016-005 | AB |
| A079016-006 | AB |
| A079016-007 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A079016-001 | ATOMOXETINE HYDROCHLORIDE | EQ 10MG BASE | CAPSULE / ORAL | AB | 2017-05-30 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A079016-002 | ATOMOXETINE HYDROCHLORIDE | EQ 18MG BASE | CAPSULE / ORAL | AB | 2017-05-30 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A079016-003 | ATOMOXETINE HYDROCHLORIDE | EQ 25MG BASE | CAPSULE / ORAL | AB | 2017-05-30 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A079016-004 | ATOMOXETINE HYDROCHLORIDE | EQ 40MG BASE | CAPSULE / ORAL | AB | 2017-05-30 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A079016-005 | ATOMOXETINE HYDROCHLORIDE | EQ 60MG BASE | CAPSULE / ORAL | AB | 2017-05-30 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A079016-006 | ATOMOXETINE HYDROCHLORIDE | EQ 80MG BASE | CAPSULE / ORAL | AB | 2017-05-30 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A079016-007 | ATOMOXETINE HYDROCHLORIDE | EQ 100MG BASE | CAPSULE / ORAL | AB | 2017-05-30 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A079016-001 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A079016-002 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A079016-003 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A079016-004 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A079016-005 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A079016-006 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A079016-007 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Atomoxetine | ATOMOXETINE | American Health Packaging | 10d36b32-0202-4c03-8a1a-cd5d53f231e7 | 2026-06-25 | Boxed warning, Warnings, Adverse reactions | 079016 ANDA079016 60687-567 |
| Atomoxetine | ATOMOXETINE | Bryant Ranch Prepack | 35b42f0c-a183-478b-bced-652dc12b33ec | 2026-04-10 | Boxed warning, Warnings, Adverse reactions | 079016 ANDA079016 |
| Atomoxetine | ATOMOXETINE | Aurobindo Pharma Limited | 6f6bea0c-297b-43ff-8960-ecc11243e06e | 2025-12-12 | Boxed warning, Warnings, Adverse reactions | 079016 ANDA079016 |
| Atomoxetine | ATOMOXETINE | Rising Pharma Holdings, Inc. | 1cceab35-dc4a-40bc-a245-10b64820e217 | 2025-12-12 | Boxed warning, Warnings, Adverse reactions | 079016 ANDA079016 |
| Atomoxetine | ATOMOXETINE | A-S Medication Solutions | 50a20478-5f33-4ecd-b5d3-dbba855e5f6b | 2025-12-10 | Boxed warning, Warnings, Adverse reactions | 079016 ANDA079016 |
| Atomoxetine | ATOMOXETINE | Bryant Ranch Prepack | d4fe9217-1853-4f8b-9a93-77e511554ca1 | 2025-06-12 | Boxed warning, Warnings, Adverse reactions | 079016 ANDA079016 |
| Atomoxetine | ATOMOXETINE | A-S Medication Solutions | 24bb7238-7e12-48d1-a572-2c753e69f604 | 2023-06-06 | Boxed warning, Warnings, Adverse reactions | 079016 ANDA079016 |
| Atomoxetine | ATOMOXETINE | A-S Medication Solutions | ffdcc267-d6ae-41ee-97d9-2c7596545ce8 | 2023-04-24 | Boxed warning, Warnings, Adverse reactions | 079016 ANDA079016 |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Atomoxetine
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| ATOMOXETINE HYDROCHLORIDE | 25 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 57WVB6I2W0 | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 10d36b32-0202-4c03-8a1a-cd5d53f231e7 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 0d16f546-db6a-1939-50fc-d06382424c97 | Product name | 4 | 20210903 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 60687-567-11 | Atomoxetine | 1 in 1 BLISTER PACK | CAPSULE | 1 | 7 | |
| 60687-567-21 | Atomoxetine | 30 in 1 BOX, UNIT-DOSE | CAPSULE | 30 | 7 |
DailyMed Dashboard NDC Coverage#
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 349593 | atomoxetine HCl 25 MG Oral Capsule | PSN | 10d36b32-0202-4c03-8a1a-cd5d53f231e7 | 7 |
| 349594 | atomoxetine HCl 40 MG Oral Capsule | PSN | 10d36b32-0202-4c03-8a1a-cd5d53f231e7 | 7 |
| 349593 | atomoxetine 25 MG Oral Capsule | SCD | 10d36b32-0202-4c03-8a1a-cd5d53f231e7 | 7 |
| 349594 | atomoxetine 40 MG Oral Capsule | SCD | 10d36b32-0202-4c03-8a1a-cd5d53f231e7 | 7 |
| 349593 | atomoxetine 25 MG (as atomoxetine hydrochloride) Oral Capsule | SY | 10d36b32-0202-4c03-8a1a-cd5d53f231e7 | 7 |
| 349594 | atomoxetine 40 MG (as atomoxetine hydrochloride) Oral Capsule | SY | 10d36b32-0202-4c03-8a1a-cd5d53f231e7 | 7 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 60687-567-11 | 60687056711 | 1 in 1 BLISTER PACK | Historical | |||||
| 60687-567-21 | 60687056721 | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-567-21) / 1 CAPSULE in 1 BLISTER PACK (60687-567-11) | 30 blister pack | 2020-12-07 | 0000-00-00 | No | No | Current |